论文信息 - Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. - 字舞流文

Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.

H. Sorbye | E. Kure | E. Skovlund | T. Christoffersen | T. Guren | E. Hofsli | B. Glimelius | T. Ikdahl | P. Pfeiffer | K. Tveit | O. Dahl | F. Hansen | M. Yilmaz | H. Starkhammar | O. Dajani | N. Keldsen | S. Pyrhonen | A. Johnsson | T. Fokstuen | F. Sigurdsson | E. Birkemeyer | Anne Berit Erdal | Elke Birkemeyer